Immune system processes

92 trials 29 recruiting

Filter these 92 trials by phase, country and sponsor.

Open in Search →

An investigator-initiated, single-center academic study in healthy transgender and cisgender persons aged between 18 and 50 years to investi… Recruiting

2024-515599-11-00 Healthy volunteers 6 2025-01-30
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared … Recruiting

2023-504022-19-01 Polymyositis or dermatomyositis according to 2017 EULAR 5 2024-12-13
A study to learn if dapirolizumab pegol works and is safe in people with moderately to severely active systemic lupus erythematosus (SLE) Recruiting

2023-508191-11-00 Systemic lupus erythematosus (SLE) 5 2024-11-28
Comparison of topical hydrocortisone versus dexamethasone treatment for inflammatory secretions of the conjunctiva in patients with ocular p… Recruiting

2024-517441-14-00 inflammatory secretions of the conjunctiva (Eye desease 11 2024-10-30
MCA-derived MSC therapy in renal transplant recipients Recruiting

2024-512553-25-00 Rejection transplanted kidney 3 2024-10-15
Rituximab-induced remission in CIDP (ReCIX study) Recruiting

2024-512506-25-00 Chronic inflammatory demyelinating polyneuropathy (CIDP 5 2024-10-07
Pan-tumor neoadjuvant basket study of immune check-point inhibition and novel IO combinations (NEOASIS) Recruiting

2023-505756-21-00 dMMR tumors consisting of but not limited to; Colorecta 4 2024-01-26
Safety and immunologic response of SHIngrix VAccination in patients suffering from Psoriasis or Psoriatic arthritis Recruiting

2024-512881-32-00 Psoriasis vulgaris and/or psoriatric arthritis 6 2023-11-22
Pneumococcal vaccine response in lymph nodes Recruiting

2022-501519-15-00 Healthy volunteers 4 2023-04-01
Integration of the PD-L1 inhibitor atezolizumab and WT1/DC vaccination into platinum/pemetrexed-based first-line treatment for epithelioid m… Recruiting

2024-515293-27-00 Malignant pleural mesothelioma, epithelioid subtype (st 4 2023-02-24
Preventive effect of Clopidogrel on the systemic sclerosis development risk Recruiting

2024-511005-39-00 Raynaud phenomenon 10 2022-06-22
A non blinded phase-II study with 3 randomized patient groups of individualized suppression of the patient's immune system with donor modifi… Recruiting

2024-513446-12-00 Living donor kidney transplantation 4 2022-05-03
INTERCEPT Study Recruiting

2024-510615-29-00 Chronic active antibody-mediated rejection in kidney tr 5 2021-05-24
HEMATOVAC-Immunogenicity of an Anti-pneumococcal Combined Vaccination (PCV13+PPV23 versus PREVENAR20) in Lymphoma Recruiting

2024-517288-22-01 Lymphoma 6 2021-01-29
MAINEPSAN : A Prospective Comparative Randomized Double-blind Placebo-controlled In-Parallel Groups Multicenter, Study to Evaluate the remis… Recruiting

2024-514156-33-00 Patients in remission for granulomatosis with polyangii 5 2019-08-20
Prospective, randomized study concerning personalized medicine with Pentaglobin® after interventional infectious source control in peritonit… Recruiting

2024-513526-27-00 secondary or quaternary peritonitis 4 2018-02-23
Wilms’ tumor (WT1) antigen-targeted dendritic cell vaccination to prevent relapse in adult patients with acute myeloid leukemia: a multicent… Ended

2024-515292-35-00 Acute Myeloid Leukemia 4 2026-01-09
IMMUNE RESET TO ALLOW ACCESS TO HLA-COMPATIBLE KIDNEY TRANSPLANTATION IN HYPERIMMUNIZED PATIENTS Ended

2023-506478-11-01 chronic kidney disease 9 2025-08-28
BESTOW-EXTENSION: A Phase 2, Multicenter, Open-Label Extension Study to Evaluate the Long- Term Safety and Efficacy of Tegoprubart in Kidney… Ended

2023-503337-21-00 Prophylaxis of Renal Allograft Rejection 4 2025-02-28
Effect of different drugs on the immune response during inflammation: the DEDICATE-LPS study Ended

2023-506556-24-00 Inflammatory response following human endotoxemia in he 4 2024-10-24
A study to find how well Dazodalibep works and how safe it is in participants with Sjögren’s Syndrome Ended

2023-503923-24-00 Sjögren’s Syndrome With Moderate-toSevere Symptom State 5 2024-07-22
Effect of nucleoside reverse transcriptase inhibitors on innate immune priming Ended

2023-510378-14-00 modulation of the innate immune system in healthy subje 3 2024-06-20
Multicentre, open-label, randomised, two-arm, parallel-group, superiority trial to assess bioavailability and practicability of two once-dai… Ended

2023-503531-18-00 Prophylaxis of transplant rejection in adult kidney all 6 2024-02-13
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic … Ended

2023-503655-10-00 Systemic Lupus Erythematosus (SLE). 5 2023-11-20